Icon

YONDELIS (nda207953)- (1MG/VIAL)

TRABECTEDIN JANSSEN PRODS
1MG/VIAL
Yes No
2028-Jul-07 2020-Oct-23
2022-Oct-23 None
None No
YONDELIS is an alkylating drug indicated for the treatment of patients with unresectable or metastatic liposarcoma or leiomyosarcoma who received a prior anthracycline-containing regimen
0 2 0
Total Other Developers 5
Drugs with Suitability No
1MG/VIAL ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.